Yang DY, Nie ZQ, Liao LZ, et al. Phenomapping of subgroups in hypertensive patients using unsupervised data-driven cluster analysis: An exploratory study of the SPRINT trial. Eur J Prev Cardiol. 2019; 26: 1693–1706.
2.
SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103–2116.
3.
RoccoMVSinkKMLovatoLC, et al.SPRINT Research Group. Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis2018; 71: 352–361.
4.
TsioufisCTousoulisD. SPRINT results are life-saving, guideline-changing, and hypertension research-intensifying. Hellenic J Cardiol2015; 56: 529–523–529–2.
5.
WilliamsBManciaGSpieringW, et al.ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J2018; 39: 3021–3104.
6.
ThomopoulosCParatiGZanchettiA. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens2014; 32: 2285–2295.
7.
EttehadDEmdinCAKiranA, et al.Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet2016; 387: 957–967.
8.
DimitriadisKTsioufisCMazarakiA, et al.Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: A 6-year follow-up study. Hypertens Res2016; 39: 475–479.
